Blossom Pro: Research Briefing #2 – More Group Therapy, No Therapy? and Personality Changes
Exploring psychedelic therapy: Beyond drugs, integrating psychotherapy and context for personality changes and mental health benefits.
Floris Wolswijk
Blossom Pro: Research Briefing #1 – 5-MeO-DMT, Group psychedelic therapy, and personality changes
Explore the latest in psychedelic research: cost-effective group therapy models, unique effects of 5-MeO-DMT, and personality changes post-experience.
The Ethical Compass of Minding to Psychotherapy: How Much Support is Necessary?
A battle of Compass Pathways (Guy Goodwin) vs the MIND Foundation (Max Wolff). The need for psychotherapy or just psychological support.
Psychedelic Research Links December 2023
This is all the other psychedelic research that came out in December 2023. These papers don’t (yet) have their own page in our database.
Psychedelic Research Recap November 2023
November’s psychedelic research saw advances in ayahuasca formulations and intriguing survey findings on naturalistic use. The month also featured complex mechanisms and tracking psychedelic states via heart rate dynamics.
Are Psychedelic Treatments a Bargain or a Burden? Examining the Cost-Effectiveness
As psychedelic treatments move towards FDA approval, what will access and affordability look like? We break down the cost-effectiveness data and challenges ahead in ensuring equitable access.
Psychedelic Research Links November 2023
This is all the other psychedelic research that came out in November 2023. These papers don’t (yet) have their own page in our database.
Innovating Mental Health in the EU Pharma Legislation: Regulatory Pathways for Psychedelic Therapies
A summary of the EU Parliament meeting on psychedelic therapies held on November 6th 2023 co-organised by PsychedelicsEUROPE.
Psychedelic Research Recap October 2023
The latest psychedelic research from October 2023, extended DMT, survey data on extended difficulties, and new trial results.
From Dreams to Psychedelics: Tommaso’s Academic Odyssey
Tommaso Barba, a visionary in psychedelic research, advances knowledge and accessibility, bridging diverse fields for a brighter future.